These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 22473991)
41. Regulation of c-Myc ubiquitination controls chronic myelogenous leukemia initiation and progression. Reavie L; Buckley SM; Loizou E; Takeishi S; Aranda-Orgilles B; Ndiaye-Lobry D; Abdel-Wahab O; Ibrahim S; Nakayama KI; Aifantis I Cancer Cell; 2013 Mar; 23(3):362-75. PubMed ID: 23518350 [TBL] [Abstract][Full Text] [Related]
42. Conditional inactivation of Fbxw7 impairs cell-cycle exit during T cell differentiation and results in lymphomatogenesis. Onoyama I; Tsunematsu R; Matsumoto A; Kimura T; de Alborán IM; Nakayama K; Nakayama KI J Exp Med; 2007 Nov; 204(12):2875-88. PubMed ID: 17984302 [TBL] [Abstract][Full Text] [Related]
43. Fbw7 isoform interaction contributes to cyclin E proteolysis. Zhang W; Koepp DM Mol Cancer Res; 2006 Dec; 4(12):935-43. PubMed ID: 17189384 [TBL] [Abstract][Full Text] [Related]
44. FBW7 increases chemosensitivity in hepatocellular carcinoma cells through suppression of epithelial-mesenchymal transition. Yu J; Zhang W; Gao F; Liu YX; Chen ZY; Cheng LY; Xie SF; Zheng SS Hepatobiliary Pancreat Dis Int; 2014 Apr; 13(2):184-91. PubMed ID: 24686546 [TBL] [Abstract][Full Text] [Related]
45. Usp28 counteracts Fbw7 in intestinal homeostasis and cancer. Diefenbacher ME; Chakraborty A; Blake SM; Mitter R; Popov N; Eilers M; Behrens A Cancer Res; 2015 Apr; 75(7):1181-6. PubMed ID: 25716680 [TBL] [Abstract][Full Text] [Related]
46. The glomuvenous malformation protein Glomulin binds Rbx1 and regulates cullin RING ligase-mediated turnover of Fbw7. Tron AE; Arai T; Duda DM; Kuwabara H; Olszewski JL; Fujiwara Y; Bahamon BN; Signoretti S; Schulman BA; DeCaprio JA Mol Cell; 2012 Apr; 46(1):67-78. PubMed ID: 22405651 [TBL] [Abstract][Full Text] [Related]
47. The Fbw7 tumor suppressor regulates nuclear factor E2-related factor 1 transcription factor turnover through proteasome-mediated proteolysis. Biswas M; Phan D; Watanabe M; Chan JY J Biol Chem; 2011 Nov; 286(45):39282-9. PubMed ID: 21953459 [TBL] [Abstract][Full Text] [Related]
48. Emerging roles of the FBW7 tumour suppressor in stem cell differentiation. Wang Z; Inuzuka H; Fukushima H; Wan L; Gao D; Shaik S; Sarkar FH; Wei W EMBO Rep; 2011 Dec; 13(1):36-43. PubMed ID: 22157894 [TBL] [Abstract][Full Text] [Related]
49. Fbw7 and its counteracting forces in stem cells and cancer: Oncoproteins in the balance. Cremona CA; Sancho R; Diefenbacher ME; Behrens A Semin Cancer Biol; 2016 Feb; 36():52-61. PubMed ID: 26410034 [TBL] [Abstract][Full Text] [Related]
50. Fbxw7/Cdc4 is a p53-dependent, haploinsufficient tumour suppressor gene. Mao JH; Perez-Losada J; Wu D; Delrosario R; Tsunematsu R; Nakayama KI; Brown K; Bryson S; Balmain A Nature; 2004 Dec; 432(7018):775-9. PubMed ID: 15592418 [TBL] [Abstract][Full Text] [Related]
51. GSK-3β regulates cell growth, migration, and angiogenesis via Fbw7 and USP28-dependent degradation of HIF-1α. Flügel D; Görlach A; Kietzmann T Blood; 2012 Feb; 119(5):1292-301. PubMed ID: 22144179 [TBL] [Abstract][Full Text] [Related]
52. Fbw7 dimerization determines the specificity and robustness of substrate degradation. Welcker M; Larimore EA; Swanger J; Bengoechea-Alonso MT; Grim JE; Ericsson J; Zheng N; Clurman BE Genes Dev; 2013 Dec; 27(23):2531-6. PubMed ID: 24298052 [TBL] [Abstract][Full Text] [Related]
53. Triggering Fbw7-mediated proteasomal degradation of c-Myc by oridonin induces cell growth inhibition and apoptosis. Huang HL; Weng HY; Wang LQ; Yu CH; Huang QJ; Zhao PP; Wen JZ; Zhou H; Qu LH Mol Cancer Ther; 2012 May; 11(5):1155-65. PubMed ID: 22389469 [TBL] [Abstract][Full Text] [Related]
54. High copy amplification of the Aurora-A gene is associated with chromosomal instability phenotype in human colorectal cancers. Nishida N; Nagasaka T; Kashiwagi K; Boland CR; Goel A Cancer Biol Ther; 2007 Apr; 6(4):525-33. PubMed ID: 17457043 [TBL] [Abstract][Full Text] [Related]
55. Targeting FBW7 as a Strategy to Overcome Resistance to Targeted Therapy in Non-Small Cell Lung Cancer. Ye M; Zhang Y; Zhang X; Zhang J; Jing P; Cao L; Li N; Li X; Yao L; Zhang J; Zhang J Cancer Res; 2017 Jul; 77(13):3527-3539. PubMed ID: 28522751 [TBL] [Abstract][Full Text] [Related]
56. Dependence of Human Colorectal Cells Lacking the FBW7 Tumor Suppressor on the Spindle Assembly Checkpoint. Bailey ML; Singh T; Mero P; Moffat J; Hieter P Genetics; 2015 Nov; 201(3):885-95. PubMed ID: 26354767 [TBL] [Abstract][Full Text] [Related]
57. Loss of Fbxw7 triggers mammary tumorigenesis associated with E2F/c-Myc activation and Trp53 mutation. Meyer AE; Furumo Q; Stelloh C; Minella AC; Rao S Neoplasia; 2020 Nov; 22(11):644-658. PubMed ID: 33070870 [TBL] [Abstract][Full Text] [Related]
58. Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7. Yada M; Hatakeyama S; Kamura T; Nishiyama M; Tsunematsu R; Imaki H; Ishida N; Okumura F; Nakayama K; Nakayama KI EMBO J; 2004 May; 23(10):2116-25. PubMed ID: 15103331 [TBL] [Abstract][Full Text] [Related]
59. Prognostic significance of Fbw7 in human melanoma and its role in cell migration. Cheng Y; Chen G; Martinka M; Ho V; Li G J Invest Dermatol; 2013 Jul; 133(7):1794-802. PubMed ID: 23381582 [TBL] [Abstract][Full Text] [Related]
60. Proteomic screen reveals Fbw7 as a modulator of the NF-κB pathway. Arabi A; Ullah K; Branca RM; Johansson J; Bandarra D; Haneklaus M; Fu J; Ariës I; Nilsson P; Den Boer ML; Pokrovskaja K; Grandér D; Xiao G; Rocha S; Lehtiö J; Sangfelt O Nat Commun; 2012; 3():976. PubMed ID: 22864569 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]